Immunocore Holdings (IMCR) Exchange Rate Effect (2021 - 2026)
Immunocore Holdings (IMCR) posted quarterly Exchange Rate Effect of -$6.1 million for Q1 2026, down 172.8% year-on-year from $8.4 million in Q1 2025, and down 322.16% on a QoQ basis from -$1.5 million in Q4 2025.
Immunocore Holdings (IMCR) Exchange Rate Effect (2021 - 2026) Analysis & Trends
Immunocore Holdings (IMCR) has reported Exchange Rate Effect for 6 consecutive years, with -$6.1 million the latest figure, recorded in Q1 2026.
- Quarterly Exchange Rate Effect fell 172.8% year-over-year to -$6.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.1 million (up 60.93% YoY) and the FY2025 annual result came in at $26.7 million, up 1660.83% from the prior year.
- Exchange Rate Effect eased to -$6.1 million in Q1 2026 per IMCR's latest filing, from -$1.5 million in the prior quarter.
- Over the last five years, Exchange Rate Effect for IMCR reached as high as $15.7 million in Q3 2022 and fell as low as -$23.3 million in Q4 2022.
- A 5-year average of $1.3 million and a median of $2.2 million in 2023 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect slumped 215504.37% — and 2025, when it jumped 7564.15%.
- Year by year, Exchange Rate Effect stood at -$23.3 million in 2022, then surged by 146.38% to $10.8 million in 2023, then sank by 220.86% to -$13.0 million in 2024, then soared by 88.85% to -$1.5 million in 2025, then plunged by 322.16% to -$6.1 million in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$6.1 million, -$1.5 million, and $7.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Immunocore Holdings | 1.80 Bn | 957.43 Mn | 106.24 Mn | -6.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.13 Mn |
| Mar 31, 2026 | -6.13 Mn |
| Dec 31, 2025 | -1.45 Mn |
| Dec 31, 2025 | -1.45 Mn |
| Sep 30, 2025 | 7.82 Mn |
| Sep 30, 2025 | 7.82 Mn |
| Jun 30, 2025 | 11.87 Mn |
| Jun 30, 2025 | 11.87 Mn |
| Mar 31, 2025 | 8.43 Mn |
| Mar 31, 2025 | 8.43 Mn |
| Dec 31, 2024 | -13.03 Mn |
| Dec 31, 2024 | -13.03 Mn |
| Sep 30, 2024 | 12.29 Mn |
| Sep 30, 2024 | 12.29 Mn |
| Jun 30, 2024 | -159,000.00 |
| Jun 30, 2024 | -159,000.00 |
| Mar 31, 2024 | -800,000.00 |
| Mar 31, 2024 | -800,000.00 |
| Dec 31, 2023 | 10.78 Mn |
| Dec 31, 2023 | 10.78 Mn |